<p>優莎娜（NYSE:USNA - 獲取免費報告）在週五發佈的報告中被 DA Davidson 的研究分析師上調至 “持有” 評級，Zacks.com 報道。</p>
<p>獲取 <strong>優莎娜</strong> 的提醒：</p>
<p>另外，StockNews.com 在週四的研究報告中將優莎娜的股票評級從 “買入” 上調至 “強力買入”。</p>
<p><strong>獲取我們關於 USNA 的最新股票報告</strong></p>
<h2>優莎娜股價下跌 3.8%</h2>
<p>週五交易時段，USNA 的股票下跌 1.33 美元，達到 33.38 美元。該公司交易了 619,779 股，較其平均交易量 84,047 股有所增加。該股票的 50 日移動平均價格為 37.96 美元，200 日移動平均價格為 40.47 美元。優莎娜的 12 個月低點為 33.28 美元，12 個月高點為 54.81 美元。該公司的市值為 6.3622 億美元，市盈率為 11.80，PEG 比率為 1.25，貝塔值為 0.89。</p>
<p>優莎娜（NYSE:USNA - 獲取免費報告）最近於 10 月 22 日發佈了季度財報。公司報告季度每股收益為 0.56 美元，超出市場共識預期的 0.49 美元，超出幅度為 0.07 美元。優莎娜的股本回報率為 10.64%，淨利潤率為 6.30%。該季度公司的收入為 2.0022 億美元，而市場共識預期為 2.0845 億美元。去年同期，該公司每股收益為 0.59 美元。研究分析師平均預測優莎娜在當前年度的每股收益為 2.45 美元。</p>
<h2>內部買賣</h2>
<p>在其他優莎娜的新聞中，董事 Gilbert A. Fuller 於 11 月 4 日星期一出售了 675 股股票。該股票以平均價格 37.71 美元出售，總交易額為 25,454.25 美元。此次出售在向 SEC 的備案中披露，相關文件可通過此鏈接獲取。公司內部人士持有該公司股票的 0.33%。</p>
<h2>優莎娜的機構交易</h2>
<p>一些對沖基金最近增加或減少了在 USNA 的持股。Safe Harbor Fiduciary LLC 在第三季度購買了優莎娜的新頭寸，價值約 30,000 美元。KBC Group NV 在第三季度將其在優莎娜的持股增加了 96.6%。KBC Group NV 現在擁有 1,056 股該公司的股票，價值 40,000 美元，此前在該期間內又購買了 519 股。Centiva Capital LP 在第三季度購買了優莎娜的新股份，價值 213,000 美元。BOKF NA 在第二季度將其在優莎娜的持股增加了 99.4%。BOKF NA 現在擁有 5,526 股該公司的股票，價值 250,000 美元，此前在上個季度又購買了 2,755 股。最後，Quest Partners LLC 在第三季度收購了優莎娜的股份，價值約 250,000 美元。54.25% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>優莎娜公司簡介</h2>
<p>（獲取免費報告）</p>
<p>優莎娜健康科學公司在亞太地區、美洲和歐洲開發、製造和銷售基於科學的營養、個人護理和護膚產品。該公司提供的優莎娜營養產品包括基礎營養/CellSentials，如提供各種年齡段全面營養的維生素和礦物質補充劑；優化劑，包括旨在滿足心血管、骨骼/結構和消化健康需求的針對性補充劑；以及包括餐替代奶昔、零食棒和其他相關產品的食品。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，優莎娜不在其中</li>
<li>資產配置：成功投資組合的關鍵。你在關注自己的投資組合嗎？</li>
<li>石油巨頭對決：埃克森美孚還是雪佛龍，誰能在 2025 年獲利？</li>
<li>如何投資生物科技股票</li>
<li>礦業股票再次成為焦點：3 個關鍵名字值得關注</li>
<li>今日最大股票虧損者 - 今日最大百分比下跌者</li>
<li>MarketBeat 週迴顧 – 12/16 - 12/20</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<p>→ 緊急：這個山寨幣機會不會等你 – 立即行動（來自加密交換利潤）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDk4NQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDk4NQ"/></p>
<h2>你現在應該投資 1,000 美元在優莎娜嗎？</h2>
<p>在考慮優莎娜之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦，現在就買入，以便在更廣泛的市場注意到之前……而優莎娜並不在名單上。</p>
<p>雖然優莎娜目前在分析師中被評為 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

優莎娜

<p>DA Davidson 將優莎娜 (NYSE:USNA) 的評級上調至 “持有”。該股票在週五下跌了 3.8%，達到 0.38 美元。優莎娜的 12 個月低點為 0.28 美元，高點為 0.81 美元。公司報告的每股收益為 0.56 美元，超出預期。內部交易方面，董事 Gilbert A. Fuller 出售了 675 股。對沖基金持有該股票的 54.25%。優莎娜在全球範圍內開發和銷售營養及個人護理產品</p>

<p>USANA Health Sciences (NYSE:USNA - Get Free Report) was upgraded by research analysts at DA Davidson to a &#34;hold&#34; rating in a report issued on Friday,Zacks.com reports.</p>
<div class="lb-trans"><p>優莎娜（NYSE:USNA - 獲取免費報告）在週五發佈的報告中被 DA Davidson 的研究分析師上調至 “持有” 評級，Zacks.com 報道。</p>
</div><p>Get <strong>USANA Health Sciences</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>優莎娜</strong> 的提醒：</p>
</div><p>Separately, StockNews.com upgraded shares of USANA Health Sciences from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday.</p>
<div class="lb-trans"><p>另外，StockNews.com 在週四的研究報告中將優莎娜的股票評級從 “買入” 上調至 “強力買入”。</p>
</div><p><strong>Get Our Latest Stock Report on USNA</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 USNA 的最新股票報告</strong></p>
</div><h2>USANA Health Sciences Trading Down 3.8 %</h2>
<div class="lb-trans"><h2>優莎娜股價下跌 3.8%</h2>
</div><p>Shares of USNA traded down $1.33 during trading hours on Friday, reaching $33.38. 619,779 shares of the company traded hands, compared to its average volume of 84,047. The stock's fifty day moving average price is $37.96 and its 200 day moving average price is $40.47. USANA Health Sciences has a 12-month low of $33.28 and a 12-month high of $54.81. The firm has a market cap of $636.22 million, a price-to-earnings ratio of 11.80, a PEG ratio of 1.25 and a beta of 0.89.</p>
<div class="lb-trans"><p>週五交易時段，USNA 的股票下跌 1.33 美元，達到 33.38 美元。該公司交易了 619,779 股，較其平均交易量 84,047 股有所增加。該股票的 50 日移動平均價格為 37.96 美元，200 日移動平均價格為 40.47 美元。優莎娜的 12 個月低點為 33.28 美元，12 個月高點為 54.81 美元。該公司的市值為 6.3622 億美元，市盈率為 11.80，PEG 比率為 1.25，貝塔值為 0.89。</p>
</div><p>USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million for the quarter, compared to the consensus estimate of $208.45 million. During the same period last year, the business posted $0.59 EPS. On average, research analysts forecast that USANA Health Sciences will post 2.45 earnings per share for the current year.</p>
<div class="lb-trans"><p>優莎娜（NYSE:USNA - 獲取免費報告）最近於 10 月 22 日發佈了季度財報。公司報告季度每股收益為 0.56 美元，超出市場共識預期的 0.49 美元，超出幅度為 0.07 美元。優莎娜的股本回報率為 10.64%，淨利潤率為 6.30%。該季度公司的收入為 2.0022 億美元，而市場共識預期為 2.0845 億美元。去年同期，該公司每股收益為 0.59 美元。研究分析師平均預測優莎娜在當前年度的每股收益為 2.45 美元。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在其他優莎娜的新聞中，董事 Gilbert A. Fuller 於 11 月 4 日星期一出售了 675 股股票。該股票以平均價格 37.71 美元出售，總交易額為 25,454.25 美元。此次出售在向 SEC 的備案中披露，相關文件可通過此鏈接獲取。公司內部人士持有該公司股票的 0.33%。</p>
</div><h2>Institutional Trading of USANA Health Sciences</h2>
<div class="lb-trans"><h2>優莎娜的機構交易</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in USNA. Safe Harbor Fiduciary LLC purchased a new position in USANA Health Sciences during the third quarter worth approximately $30,000. KBC Group NV grew its stake in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock valued at $40,000 after acquiring an additional 519 shares during the period. Centiva Capital LP purchased a new stake in USANA Health Sciences in the 3rd quarter worth $213,000. BOKF NA lifted its holdings in USANA Health Sciences by 99.4% during the second quarter. BOKF NA now owns 5,526 shares of the company's stock valued at $250,000 after purchasing an additional 2,755 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in shares of USANA Health Sciences in the third quarter valued at about $250,000. 54.25% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些對沖基金最近增加或減少了在 USNA 的持股。Safe Harbor Fiduciary LLC 在第三季度購買了優莎娜的新頭寸，價值約 30,000 美元。KBC Group NV 在第三季度將其在優莎娜的持股增加了 96.6%。KBC Group NV 現在擁有 1,056 股該公司的股票，價值 40,000 美元，此前在該期間內又購買了 519 股。Centiva Capital LP 在第三季度購買了優莎娜的新股份，價值 213,000 美元。BOKF NA 在第二季度將其在優莎娜的持股增加了 99.4%。BOKF NA 現在擁有 5,526 股該公司的股票，價值 250,000 美元，此前在上個季度又購買了 2,755 股。最後，Quest Partners LLC 在第三季度收購了優莎娜的股份，價值約 250,000 美元。54.25% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>USANA Health Sciences Company Profile</h2>
<div class="lb-trans"><h2>優莎娜公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.</p>
<div class="lb-trans"><p>優莎娜健康科學公司在亞太地區、美洲和歐洲開發、製造和銷售基於科學的營養、個人護理和護膚產品。該公司提供的優莎娜營養產品包括基礎營養/CellSentials，如提供各種年齡段全面營養的維生素和礦物質補充劑；優化劑，包括旨在滿足心血管、骨骼/結構和消化健康需求的針對性補充劑；以及包括餐替代奶昔、零食棒和其他相關產品的食品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than USANA Health Sciences</li>
<li>Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?</li>
<li>Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?</li>
<li>How to Invest in Biotech Stocks</li>
<li>Mining Stocks Back in the Spotlight: 3 Key Names to Watch</li>
<li>Biggest Stock Losers - Today’s Biggest Percentage Decliners</li>
<li>MarketBeat Week in Review – 12/16 - 12/20</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，優莎娜不在其中</li>
<li>資產配置：成功投資組合的關鍵。你在關注自己的投資組合嗎？</li>
<li>石油巨頭對決：埃克森美孚還是雪佛龍，誰能在 2025 年獲利？</li>
<li>如何投資生物科技股票</li>
<li>礦業股票再次成為焦點：3 個關鍵名字值得關注</li>
<li>今日最大股票虧損者 - 今日最大百分比下跌者</li>
<li>MarketBeat 週迴顧 – 12/16 - 12/20</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><p>→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits)(Ad)</p>
<div class="lb-trans"><p>→ 緊急：這個山寨幣機會不會等你 – 立即行動（來自加密交換利潤）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDk4NQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10985&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in USANA Health Sciences right now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在優莎娜嗎？</h2>
</div><p>Before you consider USANA Health Sciences, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮優莎娜之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦，現在就買入，以便在更廣泛的市場注意到之前……而優莎娜並不在名單上。</p>
</div><p>While USANA Health Sciences currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然優莎娜目前在分析師中被評為 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

優莎娜健康科學公司 (NYSE:USNA) 被 DA Davidson 上調至持有評級